Xolair (omalizumab) — Medica
Asthma
Initial criteria
- age ≥ 6 years
- baseline immunoglobulin E (IgE) level ≥ 30 IU/mL
- baseline positive skin test or in vitro test for allergen-specific IgE to one or more perennial and/or seasonal aeroallergens
Approval duration
4 months